Cargando…

Low levels of cathepsin D are associated with a poor prognosis in endometrial cancer

Total cytosolic cathepsin D (Cat D) levels were estimated by an immunoradiometric assay in a series of 156 consecutive patients with surgical stages I–III primary endometrial adenocarcinoma. Simultaneously, the tissue content of both oestrogen (ER) and progesterone (PR) receptors, and p185(HER-2/neu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Falcón, O, Chirino, R, León, L, López-Bonilla, A, Torres, S, Fernández, L, García-Hernández, J A, Valerón, P F, Díaz-Chico, J C
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1999
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362431/ https://www.ncbi.nlm.nih.gov/pubmed/10027332 http://dx.doi.org/10.1038/sj.bjc.6690090

Ejemplares similares

Cathepsin S in tumours, regional lymph nodes and sera of patients with lung cancer: relation to prognosis
por: Kos, J, et al.
Publicado: (2001)

Cysteine proteinase cathepsin H in tumours and sera of lung cancer patients: relation to prognosis and cigarette smoking
por: Schweiger, A, et al.
Publicado: (2000)

Microsatellite instability and ploidy status define three categories with distinctive prognostic impact in endometrioid endometrial cancer
por: Bilbao-Sieyro, Cristina, et al.
Publicado: (2014)

Down regulation of Cathepsin W is associated with poor prognosis in pancreatic cancer
por: Khojasteh-Leylakoohi, Fatemeh, et al.
Publicado: (2023)

Cathepsin-D in primary breast cancer: prognostic evaluation involving 2810 patients
por: Foekens, J A, et al.
Publicado: (1999)

Alterations in cathepsin H activity and protein patterns in human colorectal carcinomas
por: Re, E C del, et al.
Publicado: (2000)

Changes in E-cadherin associated with cytoplasmic molecules in well and poorly differentiated endometrial cancer
por: Miyamoto, S, et al.
Publicado: (2000)

Cathepsin D Inhibits Angiogenesis in Pituitary Neuroendocrine Tumors
por: Fujiwara, Ren, et al.
Publicado: (2022)

Low tumour cell proliferation at the invasive margin is associated with a poor prognosis in Dukes' stage B colorectal cancers
por: Palmqvist, R, et al.
Publicado: (1999)

Time resolved amplified FRET identifies protein kinase B activation state as a marker for poor prognosis in clear cell renal cell carcinoma
por: Miles, James, et al.
Publicado: (2017)

Cathepsin K associates with lymph node metastasis and poor prognosis in oral squamous cell carcinoma
por: Leusink, Frank K., et al.
Publicado: (2018)

Over-expression of cathepsin B in hepatocellular carcinomas predicts poor prognosis of HCC patients
por: Ruan, Jian, et al.
Publicado: (2016)

The Inhibition of Cathepsin G on Endometrial Explants With Endometrosis in the Mare
por: Amaral, Ana, et al.
Publicado: (2020)

Endometrial carcinosarcoma: a poor prognosis debut with favourable therapeutic outcome
por: Toro-Wills, María Fernanda, et al.
Publicado: (2022)

Serum anti-p53 antibodies in gastric adenocarcinoma patients are associated with poor prognosis, lymph node metastasis and poorly differentiated nuclear grade
por: Wu, C-W, et al.
Publicado: (1999)

Lysosomal protease cathepsin D is a prognostic marker in endometrial cancer.
por: Lösch, A., et al.
Publicado: (1996)

Cyclin D1 overexpression is an indicator of poor prognosis in resectable non-small cell lung cancer
por: Keum, J S, et al.
Publicado: (1999)

Immunochemical analysis of cathepsin B in lung tumours: an independent prognostic factor for squamous cell carcinoma patients
por: Werle, B, et al.
Publicado: (1999)

Time at surgery during menstrual cycle and menopause affects pS2 but not cathepsin D levels in breast cancer
por: Pujol, P, et al.
Publicado: (1999)

Cathepsin B in Eutopic and Ectopic Endometrial Tissues of Patients with Endometriosis
por: Kim, Chung-Hoon, et al.
Publicado: (2013)

CD5 and CD43 Expression are Associate with Poor Prognosis in DLBCL Patients
por: Huang, Hui, et al.
Publicado: (2018)

Loss of heterozygosity at 18q21 is indicative of recurrence and therefore poor prognosis in a subset of colorectal cancers
por: Jernvall, P, et al.
Publicado: (1999)

Human kallikrein gene 5 (KLK5) expression is an indicator of poor prognosis in ovarian cancer
por: Kim, H, et al.
Publicado: (2001)

High expression of TARS is associated with poor prognosis of endometrial cancer
por: Si, Lihui, et al.
Publicado: (2023)

Reduced expression of BAX is associated with poor prognosis in patients with epithelial ovarian cancer: a multifactorial analysis of TP53, p21, BAX and BCL-2
por: Schuyer, M, et al.
Publicado: (2001)

Expression of N-acetylglucosaminyltransferase V in endometrial cancer correlates with poor prognosis
por: Yamamoto, E, et al.
Publicado: (2007)

Loss of Annexin A10 Expression Is Associated with Poor Prognosis in Early Gastric Cancer
por: Ishikawa, Akira, et al.
Publicado: (2020)

Stage III and oestrogen receptor negativity are associated with poor prognosis after adjuvant high-dose therapy in high-risk breast cancer
por: Hohaus, S, et al.
Publicado: (1999)

Low EphA7 Expression Correlated with Lymph Node Metastasis and Poor Prognosis of Patients with Esophageal Squamous Cell Carcinoma
por: Bai, Yu-Qin, et al.
Publicado: (2015)

Low Levels of SPARC are Associated with Tumor Progression and Poor Prognosis in Human Endometrial Carcinoma
por: Wang, Ling, et al.
Publicado: (2020)

Squamous differentiation portends poor prognosis in low and intermediate-risk endometrioid endometrial cancer
por: de Andrade, Diocesio Alves Pinto, et al.
Publicado: (2019)

p16 protein expression is associated with a poor prognosis in squamous cell carcinoma of the lung
por: Huang, C-I, et al.
Publicado: (2000)

The heterogeneity of asymmetric tau distribution is associated with an early age at onset and poor prognosis in Alzheimer’s disease
por: Lu, Jiaying, et al.
Publicado: (2023)

Immunosuppressive Glycodelin A is an independent marker for poor prognosis in endometrial cancer
por: Lenhard, Miriam, et al.
Publicado: (2013)

Podocin is translocated to cytoplasm in puromycin aminonucleoside nephrosis rats and in poor-prognosis patients with IgA nephropathy
por: Fukuda, Hiromitsu, et al.
Publicado: (2015)

High Expression of SQSTM1/p62 Protein Is Associated with Poor Prognosis in Epithelial Ovarian Cancer
por: Iwadate, Reiko, et al.
Publicado: (2014)

Low Expression of RILPL2 Predicts Poor Prognosis and Correlates With Immune Infiltration in Endometrial Carcinoma
por: Liu, Jinhui, et al.
Publicado: (2021)

Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas
por: Reich, O, et al.
Publicado: (2000)

Enhanced Autophagy and Reduced Expression of Cathepsin D Are Related to Autophagic Cell Death in Epstein-Barr Virus-Associated Nasal Natural Killer/T-Cell Lymphomas: An Immunohistochemical Analysis of Beclin-1, LC3, Mitochondria (AE-1), and Cathepsin D in Nasopharyngeal Lymphomas
por: Hasui, Kazuhisa, et al.
Publicado: (2011)

Three independently deleted regions at chromosome arm 16q in human prostate cancer: allelic loss at 16q24.1–q24.2 is associated with aggressive behaviour of the disease, recurrent growth, poor differentiation of the tumour and poor prognosis for the patient
por: Elo, J P, et al.
Publicado: (1999)

Cannot write session to /tmp/vufind_sessions/sess_gvld101uvh6ttpvasdmn7ij0h1